diclofenac has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Hughes, TP | 1 |
| Kok, CH | 1 |
| Saunders, VA | 1 |
| Frede, A | 1 |
| Groot-Obbink, K | 1 |
| Osborn, M | 1 |
| Somogyi, AA | 1 |
| D'Andrea, RJ | 1 |
| White, DL | 1 |
1 other study available for diclofenac and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Diclof | 2012 |